These include an increase in CD8+ T-cells and effector memory T cells (CD44+ CD8+ CD62L+) and a decrease in Treg cells (CD4+ CD25+ Foxp3+) and M2 macrophages in the tumor microenvironment [74]. The gene discussed is FOXP3; the disease is neoplasm.